Warning: Undefined array key "file" in /var/www/vhosts/dxpx-conference.com/httpdocs/wp-includes/media.php on line 1768
dxpx general logo white text

DxPx Startup City at ADLM 2025

Sponsored by:

Showcase your innovation to the DxPx audience & network with investors and strategics right on the floor of ADLM 2025.

Package price: $3,650

Startup City Booth Benefits

A Meeting Hub and Partnering Platform for 1x1 Meetings at DxPx U.S.

You’ll receive two access codes for the DxPx partnering platform to schedule in person meetings at your booth as well as virtual
meetings around ADLM.

Three Days of Exposure to a Global Audience

Showcase your company’s USPs and investment opportunities on the floor of ADLM 2025 to 17,000 conference visitors. Your
company will be listed on the main ADLM 2025 floorplan with your own booth number, will be accessible by all ADLM visitors and will be promoted to ADLM’s global network.

Gain Exclusive Access to the Investor-Only Rooftop Reception

With this exclusive reception reserved for institutional investors, the only startups granted the right to purchase an access pass are those exhibiting at DxPx Startup City.

Maximize your time at DxPx

Our team handles all booth setup and teardown so that you can fully focus making new connections and making the most of DxPx U.S. 2025.

Invite Investors & Partners to Attend the ADLM Expo for Free

DxPx can register your investors and partners to attend the ADLM 2025 Expo at no cost. Just provide us your invite list and we’ll handle the rest. 

Limited Space - Apply Now!

We only grant booths to sponsors and innovative startups. Spaces are therefore limited to insure that every exhibitor gains the desired exposure.

Download our Startup City brochure today

Date & Location:

July 29-31, 2025 in Chicago, IL at the ADLM 2025 Clinical Lab Expo

McCormick Place Convention Center
2301 South King Dr., Chicago, IL 60616

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience